Heading Higher? Advaxis Inc. (NASDAQ: ADXS)?

Advaxis, Inc. (NASDAQ: ADXS) is gaining momentum as the stock continues to move higher in the pre-market session on Wednesday.

Market Action

ADDX stock is up by a whopping 32% to $0.64 in the pre-market session. The stock was up 14.50% on Tuesday’s trading session. Yesterday’s total volume stood at 15.92 million shares, well above its average volume of 6.34 million. The stock moved within a wide range of $0.4245 – 0.4920.

ADXS Recent News

April 28, 2021  – Advaxis to Present at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting

  • ADXS announced that it will present data from Part B of the Phase 1 study of ADXS-503 in combination with pembrolizumab at the American Society of Clinical Oncology (ASCO) Annual Meeting being held virtually, on June 4-8, 2021.
  • Title: A phase 1 study of an off-the-shelf, multi-neoantigen vector (ADXS-503) in subjects with metastatic non-small cell lung cancer (NSCLC) progressing on pembrolizumab as last therapy.
  • Session Type: Poster Session Abstract Number: 2616 Date and Time: June 4, 2021, 9:00 AM (EDT).

Trader Notes

Share Information

SHARE FLOAT (%)133.29 M (96.62%)

Recent Stock Performance

5-DAY PERF.+18.98%
1-MONTH PERF.+3.48%
3-MONTH PERF.-59.56%
6-MONTH PERF.+27.08%
YTD PERF.+39.17%
1-YEAR PERF.-32.73%

Moving Averages

+/- EMA(20)0.47 (+4.26%)
+/- SMA(50)0.62 (-20.97%)
+/- SMA(200)0.55 (-10.91%)

Pivot Points

NameS3S2S1Pivot PointsR1R2R3

Technical Indicators

CCI2020.1997NeutralChaikin Money Flow-0.0888Sell
MACD-0.0608SellMoney Flow Index36.0240Sell
STOCH (14,3)68.9756BuySTOCH RSI1.0000OverBought
UO47.4644BuyWilliams %R-31.0244Neutral

Related Posts

About The Author